← Every applicant
Unichem FDA Approvals
24 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| ALPRAZOLAMNew drugJul 13, 2026TABLET, ORAL |
| PREGABALINNew drugApr 30, 2026CAPSULE, ORAL |
| GUANFACINE HYDROCHLORIDENew drugNov 19, 2024TABLET, EXTENDED RELEASE, ORAL |
| CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDENew drugSep 10, 2024TABLET, EXTENDED RELEASE, ORAL |
| LACOSAMIDENew drugSep 4, 2024TABLET, ORAL |
| TOLTERODINE TARTRATENew drugAug 27, 2024CAPSULE, EXTENDED RELEASE, ORAL |
| FAMOTIDINENew drugJan 16, 2024FOR SUSPENSION, ORAL |
| DOXAZOSIN MESYLATENew drugJan 10, 2024TABLET, ORAL |
| PRASUGREL HYDROCHLORIDENew drugAug 28, 2023TABLET, ORAL |
| RANOLAZINENew drugMar 16, 2023TABLET, EXTENDED RELEASE, ORAL |
| EXTENDED PHENYTOIN SODIUMNew drugOct 13, 2022CAPSULE, ORAL |
| CARBAMAZEPINENew drugAug 22, 2022TABLET, ORAL |
| QUETIAPINE FUMARATENew drugAug 15, 2022TABLET, EXTENDED RELEASE, ORAL |
| LABETALOL HYDROCHLORIDENew drugAug 8, 2022TABLET, ORAL |
| NEBIVOLOL HYDROCHLORIDENew drugMar 15, 2022TABLET, ORAL |
| DIVALPROEX SODIUMNew drugFeb 25, 2022TABLET, EXTENDED RELEASE, ORAL |
| ARIPIPRAZOLENew drugDec 1, 2021TABLET, ORAL |
| METFORMIN HYDROCHLORIDENew drugAug 11, 2021TABLET, EXTENDED RELEASE, ORAL |
| AMITRIPTYLINE HYDROCHLORIDENew drugMay 19, 2021TABLET, ORAL |
| METOLAZONENew drugMar 30, 2021TABLET, ORAL |
| GUANFACINE HYDROCHLORIDENew drugMar 3, 2021TABLET, ORAL |
| APREMILASTNew drugFeb 17, 2021TABLET, ORAL |
| ZONISAMIDENew drugJan 26, 2021CAPSULE, ORAL |
| CELECOXIBNew drugJan 12, 2021CAPSULE, ORAL |